Eltrombopag in chronic idiopathic thrombocytopenic purpura.
Panzer
Simon
S
Department of Blood Group Serology and Transfusion Medicine, Division of Blood Group Serology, Medical University Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria. simon.panzer@meduniwien.ac.at
Pabinger
Ingrid
I
D001565:Benzoates / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D004311:Double-Blind Method; D006470:Hemorrhage / Q000209:etiology; D006801:Humans; D006834:Hydrazines / Q000009:adverse effects / Q000627:therapeutic use*; D015337:Multicenter Studies as Topic; D010976:Platelet Count; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D011720:Pyrazoles / Q000009:adverse effects / Q000627:therapeutic use*; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic
D001565:Benzoates; D006834:Hydrazines; D011720:Pyrazoles; C520809:eltrombopag